Polymyositis and Dermatomyositis

USMLE Step 1 trap: Confuses IBM's asymmetric distal-predominant weakness pattern with the proximal symmetric weakness of polymyositis. IBM causes asymmetric weakness that preferentially affects distal muscles (finger flexors, foot extensors) in addition to proximal muscles, distinguishing it from polymyositis.

Polymyositis and dermatomyositis are inflammatory myopathies that USMLE Step 1 loves to test through clinical vignettes — a patient with proximal muscle weakness, elevated CK, and either a classic rash or a specific autoantibody. The core concept is straightforward: symmetric proximal muscle weakness + elevated muscle enzymes + inflammatory infiltrate on biopsy. What makes this topic high-yield is that the exam doesn't just ask you to name the disease — it asks you to distinguish between polymyositis, dermatomyositis, and inclusion body myositis based on subtle clinical and histological differences, then apply that distinction to management or complication questions.

The trickiest part is keeping the antibody-to-syndrome mapping clean. Anti-Jo-1 trips up a lot of students who link it to dermatomyositis because they learned 'Jo-1 = myositis.' That's incomplete — anti-Jo-1 defines antisynthetase syndrome, which is polymyositis plus interstitial lung disease plus mechanic's hands plus Raynaud phenomenon. Anti-Mi-2 is the antibody actually associated with dermatomyositis. Anti-MDA5 is associated with clinically amyopathic DM and aggressive ILD. Getting these wrong on USMLE Step 1 will cost you points on both the primary question and any follow-up about complications.

Dermatomyositis also has a malignancy association that polymyositis does not share to the same degree — this is a tested complication, not a footnote. A vignette describing a middle-aged patient with Gottron papules and new-onset weakness should immediately trigger cancer screening in your mind. Inclusion body myositis (IBM) is the curveball: it mimics polymyositis at first glance but has features that make it stand apart — asymmetric, distal-predominant weakness, older age of onset, and most importantly, it does not respond to steroids.

From real student decks

65%have cards covering this topic

49%have mature cards

Common misconceptions

Common mistake

Wrong: Inclusion body myositis (IBM) causes proximal symmetric weakness like polymyositis.

Right: IBM causes asymmetric weakness that preferentially affects distal muscles (finger flexors, foot extensors) in addition to proximal muscles, distinguishing it from polymyositis.

IBM does have proximal muscle involvement, which is why it gets confused with polymyositis — but the key distinguishing feature is that IBM also causes distal weakness, particularly finger flexor weakness and foot drop, and this weakness is asymmetric. Polymyositis is symmetric and spares distal muscles. When a vignette describes an older patient whose grip strength is disproportionately affected, think IBM. The rimmed vacuoles on biopsy seal the diagnosis.

Common mistake

Wrong: Polymyositis carries the same malignancy risk as dermatomyositis.

Right: Dermatomyositis has a significantly higher association with underlying malignancy than polymyositis, requiring age-appropriate cancer screening at diagnosis.

This is a tested clinical distinction, not a nuance. Dermatomyositis has a strong and well-established association with malignancy — ovarian, lung, GI, and breast cancers are most common — whereas polymyositis has only a modestly elevated risk. The mechanism isn't fully understood, but the exam expects you to know that a DM diagnosis obligates you to screen for cancer. If the vignette describes a patient with Gottron papules or heliotrope rash, cancer workup is part of the answer.

Common mistake

Gap: Misses that both heliotrope rash and Gottron papules are pathognomonic skin findings specific to dermatomyositis

Dermatomyositis has two pathognomonic skin findings: heliotrope rash (periorbital violaceous discoloration) and Gottron papules (erythematous papules over the MCP and PIP joints).

Both findings are pathognomonic, meaning they appear in dermatomyositis and essentially nowhere else — you need to know both. The heliotrope rash is the violaceous (purple-red) discoloration of the upper eyelids, often with periorbital edema. Gottron papules are the raised erythematous papules over the dorsal MCP and PIP joints — distinct from the flat Gottron sign, which is erythema over those same joints. USMLE Step 1 may describe either or both; missing one means missing the diagnosis.

Common mistake

Wrong: Anti-Jo-1 antibody is associated with dermatomyositis skin findings.

Right: Anti-Jo-1 is associated with antisynthetase syndrome (polymyositis + interstitial lung disease + mechanic's hands + Raynaud), not primarily with dermatomyositis skin findings.

Anti-Jo-1 is an anti-aminoacyl-tRNA synthetase antibody — hence 'antisynthetase syndrome.' It is associated with a specific clinical package: inflammatory myopathy (usually polymyositis-like), interstitial lung disease, mechanic's hands (cracked, fissured skin on the lateral fingers), Raynaud phenomenon, and arthritis. The dermatomyositis-specific antibody is anti-Mi-2, and anti-MDA5 is associated with amyopathic DM and rapidly progressive ILD. Keeping this mapping straight will protect you on antibody-to-syndrome questions.

Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →

Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

Recognize the classic presentation of polymyositis: symmetric proximal muscle weakness (difficulty rising from a chair, lifting arms overhead), elevated CK and aldolase, and anti-Jo-1 antibody pointing toward antisynthetase syndrome with ILD.
Identify dermatomyositis by its two pathognomonic skin findings — heliotrope rash (violaceous periorbital discoloration with edema) and Gottron papules (erythematous papules over the MCP and PIP joints) — and know that shawl sign and mechanic's hands are also associated.
Know that dermatomyositis carries a significantly higher risk of underlying malignancy than polymyositis, and that cancer screening (age-appropriate, CT chest/abdomen/pelvis) is indicated at the time of diagnosis.
Distinguish inclusion body myositis from polymyositis: IBM causes asymmetric, distal-predominant weakness (finger flexors, foot extensors affected), occurs in older patients (>50), shows rimmed vacuoles on muscle biopsy, and does not respond to steroids.
Apply the stepwise management of polymyositis and dermatomyositis: high-dose glucocorticoids first, then steroid-sparing agents (methotrexate, azathioprine) if needed — and recognize that IBM is notably steroid-resistant.

Can you avoid these mistakes?

A 45-year-old woman presents with 3 months of difficulty climbing stairs and raising her arms above her head. Labs show CK 2,400 U/L and a positive anti-Jo-1 antibody. Chest CT reveals bilateral ground-glass opacities. What syndrome does this represent, and what additional physical finding should you look for on her hands?

You see a 58-year-old man with proximal leg weakness and difficulty gripping objects. His weakness is worse in the right hand than the left. CK is mildly elevated. Muscle biopsy shows mononuclear infiltrates and rimmed vacuoles. You start high-dose prednisone — what do you expect to happen, and why?

A 62-year-old woman is diagnosed with dermatomyositis based on heliotrope rash and confirmed muscle biopsy. She asks whether she needs any additional workup. What do you tell her, and what is the evidence-based rationale?

Match the antibody to the correct clinical association: (1) Anti-Mi-2, (2) Anti-Jo-1, (3) Anti-MDA5. Associations: (A) antisynthetase syndrome with ILD and mechanic's hands, (B) dermatomyositis with classic skin findings, (C) amyopathic dermatomyositis with rapidly progressive ILD.

Polymyositis and Dermatomyositis

Common misconceptions

What the exam tests

Can you avoid these mistakes?

Related topics